Libre, a leading infrastructure platform, has partnered with Nomura's Laser Digital to launch institutional investment funds on the Injective blockchain.
Institutional Tokenization of Private Funds
The partnership between Libre and Injective enables institutional and accredited investors to access the world's largest financial firms through blockchain-based tokenization. Key institutional funds are now available on-chain, including Laser Carry Fund (LCF), BlackRock Money Market Fund, and Hamilton Lane SCOPE Senior Credit Fund.
How Libre’s Tokenization Framework Works
Libre's real-world asset tokenization turns traditional financial instruments into blockchain tokens, improving liquidity, transparency, and efficiency. The process involves asset conversion to tokens, fractional ownership, and integration with DeFi. Key benefits include lower fees, faster settlements, and 24/7 trading.
Why Injective? A Blockchain Built for Institutional Finance
Injective is emerging as the go-to blockchain for institutional finance, offering high-performance infrastructure. Key features include an advanced decentralized order book, fast finality, and low fees. Deutsche Telekom recently joined as a validator, enhancing Injective's security and reliability.
The integration of Libre and Nomura with Injective marks a major step towards the mass institutional adoption of DeFi, providing a new avenue for traditional financial products in decentralized ecosystems.
